Diabetes is a major cause of heart disease and stroke, and the leading cause of kidney failure. It's a condition that impacts nearly 26 million people in the U.S., or 8.3 percent of the population, and, if current trends continue, as many as 1 in 3 U.S. adults could have diabetes by 2050. That's why Alere™ Health, LLC, and AT&T are teaming up to provide patients with a better way to manage and control their diabetes.
The companies will jointly deliver DiabetesManager®, an end-to-end mobile health (mHealth) diabetes solution powered by WellDoc® that will help adults with type 2 diabetes manage their health and engage with their caregivers. Alere Health, a division of Alere Inc. and a leading provider of personal health support solutions, and the largest U.S. provider of specialized, patient-centered health management services, currently manages over 290,000 individuals with diabetes.
This solution will complement Alere's mHealth solution portfolio, enabling a more dynamic and personalized approach for the engagement and participation of members diagnosed with diabetes. FDA-cleared DiabetesManager will be targeted for higher risk, higher acuity patients, in contrast to Alere's Mya solution that is designed for lower risk, lower acuity patients.
"There are hundreds of mHealth diabetes applications in the market today; however, this solution will be one of the first to be fully connected to a clinical system as part of an integrated plan of care," said Mike Cotton, CEO of Alere Health. "It goes beyond providing real-time coaching to the patient and enables the valuable patient information collected to be shared with nurses, case workers and doctors, who can communicate directly with the patient if needed."
"This collaboration combines best-in-class healthcare management services from Alere with best-in-class technology solutions from AT&T," said Randall Porter, Assistant Vice President, AT&T ForHealthSM, AT&T Business Solutions. "The innovative mHealth solution connects patients to Alere's care managers to help promote behavior that can lead to healthier outcomes."
The companies will jointly market and sell the solution to health plans, insurers and corporate payers. The solution will be part of Alere's care management portfolio and is expected to be available in the third quarter.